{"data":[{"accessionNo":"0001831942-26-000036","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001812364","issuerName":"Relay Therapeutics, Inc.","ticker":"RLAY","cusip":"75943R102","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Michael Kramarz","reportingCik":null,"personType":"HC,IN","sharesOwned":12000000,"percentOfClass":5.5,"filedAt":"2026-08-14"},{"accessionNo":"0001831942-26-000036","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001812364","issuerName":"Relay Therapeutics, Inc.","ticker":"RLAY","cusip":"75943R102","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Commodore Capital LP","reportingCik":null,"personType":"IA,PN","sharesOwned":12000000,"percentOfClass":5.5,"filedAt":"2026-08-14"},{"accessionNo":"0001831942-26-000036","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001812364","issuerName":"Relay Therapeutics, Inc.","ticker":"RLAY","cusip":"75943R102","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Robert Egen Atkinson","reportingCik":null,"personType":"HC,IN","sharesOwned":12000000,"percentOfClass":5.5,"filedAt":"2026-08-14"},{"accessionNo":"0001831942-26-000036","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001812364","issuerName":"Relay Therapeutics, Inc.","ticker":"RLAY","cusip":"75943R102","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Commodore Capital Master LP","reportingCik":null,"personType":"PN","sharesOwned":12000000,"percentOfClass":5.5,"filedAt":"2026-08-14"},{"accessionNo":"0001193125-26-342308","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001812364","issuerName":"RELAY THERAPEUTICS, INC.","ticker":"RLAY","cusip":"75943R102","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Joseph Edelman","reportingCik":null,"personType":"IN","sharesOwned":14106187,"percentOfClass":6.4,"filedAt":"2026-08-10"},{"accessionNo":"0001193125-26-342308","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001812364","issuerName":"RELAY THERAPEUTICS, INC.","ticker":"RLAY","cusip":"75943R102","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Perceptive Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":14106187,"percentOfClass":6.4,"filedAt":"2026-08-10"},{"accessionNo":"0001193125-26-342308","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001812364","issuerName":"RELAY THERAPEUTICS, INC.","ticker":"RLAY","cusip":"75943R102","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Perceptive Life Sciences Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":14106187,"percentOfClass":6.4,"filedAt":"2026-08-10"},{"accessionNo":"0000315066-26-002255","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001812364","issuerName":"RELAY THERAPEUTICS INC","ticker":"RLAY","cusip":"75943R102","securityClass":"COMMON STOCK","eventDate":"2026-07-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":21270751.24,"percentOfClass":10,"filedAt":"2026-08-07"},{"accessionNo":"0000315066-26-002255","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001812364","issuerName":"RELAY THERAPEUTICS INC","ticker":"RLAY","cusip":"75943R102","securityClass":"COMMON STOCK","eventDate":"2026-07-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":21270751.24,"percentOfClass":10,"filedAt":"2026-08-07"},{"accessionNo":"0000315066-26-002113","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001812364","issuerName":"RELAY THERAPEUTICS INC","ticker":"RLAY","cusip":"75943R102","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":20015113.24,"percentOfClass":9.4,"filedAt":"2026-08-06"},{"accessionNo":"0000315066-26-002113","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001812364","issuerName":"RELAY THERAPEUTICS INC","ticker":"RLAY","cusip":"75943R102","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":20015113.24,"percentOfClass":9.4,"filedAt":"2026-08-06"},{"accessionNo":"0000919574-26-003486","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001812364","issuerName":"Relay Therapeutics, Inc.","ticker":"RLAY","cusip":"75943R102","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-15"},{"accessionNo":"0000919574-26-003486","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001812364","issuerName":"Relay Therapeutics, Inc.","ticker":"RLAY","cusip":"75943R102","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-15"},{"accessionNo":"0000919574-26-003486","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001812364","issuerName":"Relay Therapeutics, Inc.","ticker":"RLAY","cusip":"75943R102","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-15"},{"accessionNo":"0001193125-26-152824","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001812364","issuerName":"KIORA PHARMACEUTICALS, INC.","ticker":"RLAY","cusip":"49721T507","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-04-06","reportingPerson":"Perceptive Life Sciences Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":438471,"percentOfClass":9.99,"filedAt":"2026-04-13"},{"accessionNo":"0001193125-26-152824","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001812364","issuerName":"KIORA PHARMACEUTICALS, INC.","ticker":"RLAY","cusip":"49721T507","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-04-06","reportingPerson":"Perceptive Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":438471,"percentOfClass":9.99,"filedAt":"2026-04-13"},{"accessionNo":"0001193125-26-152824","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001812364","issuerName":"KIORA PHARMACEUTICALS, INC.","ticker":"RLAY","cusip":"49721T507","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-04-06","reportingPerson":"Joseph Edelman","reportingCik":null,"personType":"IN","sharesOwned":438471,"percentOfClass":9.99,"filedAt":"2026-04-13"},{"accessionNo":"0000102909-26-002139","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001812364","issuerName":"Relay Therapeutics Inc","ticker":"RLAY","cusip":"75943R102","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27"},{"accessionNo":"0001193125-26-115967","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001812364","issuerName":"RELAY THERAPEUTICS, INC.","ticker":"RLAY","cusip":"75943R102","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-12","reportingPerson":"Perceptive Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":9404725,"percentOfClass":5.3,"filedAt":"2026-03-19"},{"accessionNo":"0001193125-26-115967","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001812364","issuerName":"RELAY THERAPEUTICS, INC.","ticker":"RLAY","cusip":"75943R102","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-12","reportingPerson":"Joseph Edelman","reportingCik":null,"personType":"IN","sharesOwned":9404725,"percentOfClass":5.3,"filedAt":"2026-03-19"},{"accessionNo":"0001193125-26-115967","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001812364","issuerName":"RELAY THERAPEUTICS, INC.","ticker":"RLAY","cusip":"75943R102","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-12","reportingPerson":"Perceptive Life Sciences Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":9404725,"percentOfClass":5.3,"filedAt":"2026-03-19"},{"accessionNo":"0000919574-26-001221","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001812364","issuerName":"Relay Therapeutics, Inc.","ticker":"RLAY","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"ELI CASDIN","reportingCik":null,"personType":"HC,IN","sharesOwned":13003574,"percentOfClass":7.5,"filedAt":"2026-02-17"},{"accessionNo":"0000919574-26-001220","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001812364","issuerName":"Relay Therapeutics, Inc.","ticker":"RLAY","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"CASDIN PARTNERS GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":13003574,"percentOfClass":7.5,"filedAt":"2026-02-17"},{"accessionNo":"0000919574-26-001220","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001812364","issuerName":"Relay Therapeutics, Inc.","ticker":"RLAY","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"ELI CASDIN","reportingCik":null,"personType":"HC,IN","sharesOwned":13003574,"percentOfClass":7.5,"filedAt":"2026-02-17"},{"accessionNo":"0000919574-26-001221","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001812364","issuerName":"Relay Therapeutics, Inc.","ticker":"RLAY","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"CASDIN CAPITAL, LLC","reportingCik":null,"personType":"IA","sharesOwned":13003574,"percentOfClass":7.5,"filedAt":"2026-02-17"},{"accessionNo":"0000919574-26-001221","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001812364","issuerName":"Relay Therapeutics, Inc.","ticker":"RLAY","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"CASDIN PARTNERS GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":13003574,"percentOfClass":7.5,"filedAt":"2026-02-17"},{"accessionNo":"0000919574-26-001220","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001812364","issuerName":"Relay Therapeutics, Inc.","ticker":"RLAY","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"CASDIN CAPITAL, LLC","reportingCik":null,"personType":"IA","sharesOwned":13003574,"percentOfClass":7.5,"filedAt":"2026-02-17"},{"accessionNo":"0000919574-26-001220","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001812364","issuerName":"Relay Therapeutics, Inc.","ticker":"RLAY","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"CASDIN PARTNERS MASTER FUND, L.P.","reportingCik":null,"personType":"PN","sharesOwned":12585000,"percentOfClass":7.3,"filedAt":"2026-02-17"},{"accessionNo":"0000919574-26-001221","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001812364","issuerName":"Relay Therapeutics, Inc.","ticker":"RLAY","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"CASDIN PARTNERS MASTER FUND, L.P.","reportingCik":null,"personType":"PN","sharesOwned":12585000,"percentOfClass":7.3,"filedAt":"2026-02-17"},{"accessionNo":"0001831942-25-000024","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001812364","issuerName":"Relay Therapeutics, Inc.","ticker":"RLAY","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Robert Egen Atkinson","reportingCik":null,"personType":"HC,IN","sharesOwned":17000000,"percentOfClass":9.9,"filedAt":"2025-11-14"},{"accessionNo":"0001831942-25-000024","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001812364","issuerName":"Relay Therapeutics, Inc.","ticker":"RLAY","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Commodore Capital LP","reportingCik":null,"personType":"IA,PN","sharesOwned":17000000,"percentOfClass":9.9,"filedAt":"2025-11-14"},{"accessionNo":"0001831942-25-000024","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001812364","issuerName":"Relay Therapeutics, Inc.","ticker":"RLAY","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Commodore Capital Master LP","reportingCik":null,"personType":"PN","sharesOwned":17000000,"percentOfClass":9.9,"filedAt":"2025-11-14"},{"accessionNo":"0001831942-25-000024","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001812364","issuerName":"Relay Therapeutics, Inc.","ticker":"RLAY","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Michael Kramarz","reportingCik":null,"personType":"HC,IN","sharesOwned":17000000,"percentOfClass":9.9,"filedAt":"2025-11-14"}],"updatedAt":"2026-09-20T08:08:36.428Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data"}